NEW YORK, Feb 23 (Reuters) - Bayer (BAYGn.DE), opens new tab sued Johnson & Johnson (JNJ.N), opens new tab on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The President officially designated elemental phosphorus as a “scarce material that is critical to national defense and security,” citing its pervasive role in military readiness and agricultural ...

Bayer is proposing a $7.25 billion plan to settle thousands of lawsuits claiming its Roundup weedkiller caused cancer — a high-stakes effort to cap years of mounting legal exposure that will pressure ...

Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin ...

Bayer stock slumped on Wednesday as the German giant set a preliminary accord to cap litigation over its weedkiller Roundup. Bayer late Tuesday said it’s agreed to settle current and potential cases ...

Bayer BAYN-2.16%decrease; red down pointing triangle is making a new multibillion-dollar push to resolve a yearslong legal nightmare over Roundup weedkiller. The German pharmaceutical and agriculture ...

Feb. 17 (UPI) --Officials for Germany-based Bayer have agreed to pay $7.25 billion to settle a class action filed by those who say its Roundup weedkiller caused them or their loved ones to develop ...

Bayer AG agreed to pay more than $7 billion as part of a major push to resolve current and future cancer lawsuits over its top-selling Roundup weedkiller in a settlement plan to turn the page on ...

The nationwide class action settlement, designed to resolve tens of thousands of claims, comes after more than a decade of litigation tying Roundup to non-Hodgkin lymphoma. In an investor call, Bayer ...

German chemical giant Bayer has agreed to pay $7.25 billion to settle thousands of lawsuits alleging its Roundup weedkiller causes cancer. The proposed settlement — which must be approved by a St.

The agreement, which still faces legal hurdles, would cover current and future claims that the weedkiller caused non-Hodgkin’s lymphoma. By Kevin Draper Bayer, the German pharmaceutical and biotech ...